tacrolimu
immunophilin
inhibit
viral
replic
b
r
c
recent
research
shown
coronaviru
cov
replic
depend
activ
immunophilin
pathway
demonstr
drug
tacrolimu
inhibit
strongli
growth
human
coronavirus
sarscov
low
noncytotox
concentr
cell
cultur
shown
plaqu
titrat
qpcr
luciferaseand
green
fluoresc
protein
gfp
report
gene
express
replic
diminish
sever
order
magnitud
knockdown
cellular
protein
cell
prevent
replic
suggest
requir
member
immunophilin
famili
viru
growth
elsevi
bv
right
reserv
coronavirus
caus
sever
diseas
respiratori
gastrointestin
tract
central
nervou
system
anim
perlman
netland
infect
human
known
sinc
associ
respiratori
tract
ie
common
cold
diseas
sever
acut
respiratori
syndromecoronaviru
sarscov
aggress
human
agent
caus
lung
diseas
sar
drosten
et
al
discov
respect
van
der
hoek
et
al
woo
et
al
caus
upper
lower
respiratori
tract
infect
includ
bronchiol
pneumonia
especi
young
children
immunocompromis
patient
elderli
van
der
hoek
effect
treatment
coronaviru
infect
human
unavail
stockman
et
al
even
though
inhibitor
coronaviru
enzym
review
tong
b
compound
inhibit
vitro
replic
describ
abbrevi
effect
inhibitori
concentr
rlu
rel
light
unit
correspond
author
email
address
vonbrunn
mvpunimuenchend
von
brunn
kono
et
al
te
velthui
et
al
vincent
et
al
coronavirus
repres
group
rna
virus
largest
rna
genom
known
date
compar
rna
virus
coronaviru
polymeras
rather
low
error
frequenc
may
possess
rna
proof
read
activ
denison
et
al
howev
develop
resist
mutant
presenc
drug
target
coronavir
protein
remain
seriou
concern
viru
replic
depend
varieti
host
factor
de
haan
rottier
vogel
et
al
zhang
et
al
turn
repres
potenti
antivir
target
might
prefer
target
viral
protein
develop
resist
much
less
like
recent
studi
perform
genomewid
sarscov
yeasttwohybrid
interact
screen
human
cdna
librari
identifi
cyclophilin
protein
interact
partner
sarscov
nonstructur
protein
identifi
cyclosporin
csa
potent
replic
inhibitor
variou
human
anim
cov
pfefferl
et
al
inhibit
sarscov
addit
mous
hepat
viru
also
confirm
de
wild
et
al
de
wild
et
al
cyclophilin
protein
collect
refer
immunophilin
bind
immunosuppress
drug
csa
respect
furthermor
share
peptidylprolyl
isomeras
ppias
domain
chaperon
function
facilit
protein
fold
davi
et
al
csa
recent
shown
exert
inhibitori
effect
herp
simplex
viru
vaccinia
viru
damaso
keller
bk
polyoma
viru
acott
et
al
human
immunodefici
viru
brigg
et
al
wainberg
et
al
hcv
fischer
et
al
nakagawa
et
al
watashi
et
al
wherea
cyclophilin
report
requir
replic
frank
luban
vesicular
stomat
viru
bose
et
al
hcv
nakagawa
et
al
protein
found
play
role
replic
brigg
et
al
hcv
nakagawa
et
al
watashi
et
al
orthopoxvirus
inhibit
rei
et
al
one
first
macrolid
discov
bacterium
streptomyc
tsukubaensi
immunosuppress
activ
although
structur
unrel
cyclic
undecapeptid
csa
molecul
display
similar
properti
bind
catalyt
pocket
ppias
domain
cellular
bind
partner
result
inhibit
ppias
activ
barik
furthermor
cyclophilincsa
complex
bind
cellular
phosphatas
calcineurin
cna
inhibit
dephosphoryl
activ
nuclear
factor
activ
tcell
inhibit
essenti
transcript
regul
import
immun
gene
caus
immunosuppress
import
note
bind
complex
cna
requir
immunosuppress
inhibit
ppias
activitiy
respons
antivir
activ
two
independ
mechan
studi
interact
sarscov
protein
cyclophilin
b
discov
replic
variou
coronavirus
sensit
csa
treatment
includ
pfefferl
et
al
sinc
also
interact
protein
examin
studi
whether
inhibit
replic
human
coronavirus
first
experi
verofm
cell
infect
sarscov
multipl
infect
moi
presenc
increas
concentr
csa
viru
rna
concentr
measur
h
supernat
infect
cell
realtim
rtpcr
drosten
et
al
titer
reduc
csa
fold
respect
fig
show
percentag
sarscov
inhibit
influenc
ec
inhibitori
concentr
fig
correspond
log
titer
reduct
repres
examin
whether
exert
inhibitori
activ
human
coronavirus
cell
infect
moi
herzog
et
al
presenc
increas
inhibitor
concentr
two
day
rna
cell
cultur
supernat
harvest
viral
rna
extract
use
high
pure
viral
nucleic
acid
kit
roch
quantifi
realtim
pcr
use
superscript
tm
iii
onestep
quantit
system
rox
invitrogen
allow
revers
transcript
cdna
synthesi
pcr
amplif
singl
step
pcr
primer
use
genom
posit
nt
genom
posit
nt
probe
genom
posit
nt
ec
inhibitori
concentr
replic
complet
inhibit
fig
reflect
reduct
viru
replic
fig
concentr
cell
viabil
celltiterglo
promega
still
inhibit
viru
growth
cell
also
confirm
plaqu
titrat
assay
herzog
et
al
use
serial
viru
dilut
presenc
concentr
rang
fig
f
show
percentag
log
reduct
inhibit
viru
replic
respect
condit
plaqu
assay
involv
viru
growth
four
day
decreas
viru
titer
occur
linear
fashion
ec
e
complet
inhibit
observ
reduct
five
order
magnitud
f
virus
express
renilla
luciferas
pfefferl
et
al
gfp
cervant
barragan
et
al
report
gene
use
examin
inhibitori
effect
cell
infect
moi
incub
two
day
presenc
increas
concentr
cultur
medium
viral
replic
determin
measur
renilla
luciferas
activ
fig
b
show
percent
log
reduct
viru
growth
respect
found
effect
ec
cell
viabil
reduc
compar
untreat
cell
indic
viru
reduct
due
drug
cell
death
fig
show
microscop
comparison
infect
increas
concentr
csa
reduct
viru
infect
quantifi
determin
fluoresc
intens
microscop
imag
infect
cell
pictur
analys
use
softwar
imagej
abramoff
et
al
rasband
rasband
integr
densiti
three
differ
region
interest
measur
pictur
obtain
averag
use
calcul
correl
viru
replic
effici
determin
ec
condit
gfp
fluoresc
invers
correl
inhibitor
concentr
dapi
stain
cell
nuclei
indic
confluenc
cell
equival
cell
densiti
concentr
step
viru
growth
complet
abolish
concentr
csa
latter
correl
well
inhibitori
concentr
determin
ec
valu
higher
plaqu
gfp
titrat
compar
direct
replic
assay
either
rtpcr
luciferas
measur
howev
deviat
assay
format
factor
order
examin
whether
cellular
protein
requir
viru
replic
knockdown
cell
line
establish
use
lentivir
express
shrna
sirion
gmbh
martinsri
germani
cell
transduc
moi
missiontm
lentivir
nontarget
control
cyclophilin
b
ppib
shrna
lentivirus
sequenc
use
gene
knockdown
list
tabl
stabl
shrnaexpress
cell
gener
week
bulkselect
gml
puromycincontain
medium
dmem
fc
mm
lglutamin
mm
napyruv
high
puromycin
concentr
need
select
cell
might
result
enhanc
express
multi
drug
resist
protein
gene
deplet
cell
effici
inhibitori
drug
molecul
takara
et
al
bulkselect
knockdown
control
cell
mrna
express
quantifi
realtim
rtpcr
revers
transcript
g
total
rna
use
amplif
product
detect
sybr
amplicon
integr
verifi
melt
point
analysi
cyclophilin
ppia
serv
refer
gene
ppib
determin
specif
knockdown
mrna
express
level
ppib
determin
realtim
rtpcr
primer
list
tabl
fig
show
ppib
mrna
express
bulkselect
cell
comparison
nontarget
control
knockdown
determin
ppib
respect
plaqu
titrat
show
grew
similar
titer
wild
type
shown
shrna
control
knockdown
cell
indic
express
ppib
necessari
viral
growth
convers
knockdown
ab
result
plaqu
format
identifi
product
key
protein
requir
viral
replic
similarli
realtim
pcr
amplif
rna
genom
supernat
cell
line
show
significantli
reduc
titer
knockdown
cell
compar
knockdown
cell
shown
confirm
result
plaqu
titrat
summari
inhibit
replic
sarscov
nontox
lowmicromolar
concentr
reduct
viru
titer
sever
order
magnitud
undetect
level
compar
studi
effect
csa
former
inhibit
viru
replic
complet
ic
gml
wherea
latter
inhibitori
effect
chronic
newli
infect
cell
gml
brigg
et
al
also
case
hcv
effect
replic
replicon
rna
concentr
gml
watashi
et
al
consid
higher
drug
concentr
csa
need
inhibit
coronaviru
replic
specul
also
hcv
might
inhibit
higher
concentr
also
remain
clarifi
low
nanomolar
affin
reflect
inhibitori
concentr
coronavirus
resid
low
micromolar
rang
might
explain
stronger
affin
coronaviru
protein
cellular
protein
compar
lack
growth
stabl
ppib
knockdown
mutant
indic
requir
replic
two
protein
share
homolog
amino
acid
level
shown
substitut
upon
individu
knockdown
common
structur
featur
fkbp
protein
ppias
domain
also
call
domain
peptidylprolyl
cistran
isomeras
activ
influenc
cellular
pathway
bind
cellular
protein
kang
et
al
activ
common
mani
fkbp
famili
member
contain
ppias
domain
separ
chaperon
function
discrimin
barik
two
less
pathogen
coronavirus
highli
pathogen
sarscov
sensit
csa
indic
involv
cyclophilin
protein
viral
replic
howev
clear
function
cellular
protein
requir
viru
replic
sarscov
shown
bind
cyclophilin
lumier
assay
pfefferl
et
al
also
protein
interact
shown
mechan
function
interact
analys
detail
furthermor
clarifi
whether
viral
protein
involv
relat
coronavirus
immunophilin
